RELETRANS TRANSDERMAL PATCHES - Rowex Consumer Healthcare

TYPE: Controlled

BRAND: Reletrans Transdermal Patches

ACTIVE INGREDIENT: buprenorphine

STRENGTH, PACK SIZE & GMS CODES:

Reletrans 5 micrograms/hour Transdermal Patches x 4 patches – 42726

Reletrans 10 micrograms/hour Transdermal Patches x 4 patches – 42727

Reletrans 15 micrograms/hour Transdermal Patches x 4 patches – 42728

Reletrans 20 micrograms/hour Transdermal Patches x 4 patches – 42729

INDICATION:

Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia.

Reletrans is not suitable for the treatment of acute pain.

Reletrans is indicated in adults.